Vivani Medical, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2024 Annual Meeting of Stockholders held on June 27, 2024. The filing date is June 28, 2024. Vivani Medical, Inc. is a Delaware corporation with its principal executive offices in Alameda, California, and its common stock trades on The Nasdaq Capital Market under the symbol "VANI".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.
Material Changes and Voting Results
A quorum was established with 35,232,561 of 54,978,465 shares represented. The following matters were approved:
- Proposal 1 (Director Elections): All six nominees were elected to the Board of Directors. Votes for ranged from approximately 24.05 million to 24.26 million per nominee, with significant broker non-votes (approx. 10.9 million) recorded for each.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of BPM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The vote was 34,974,648 for, 195,530 against, and 62,383 abstained.
- Proposal 3 (Say-on-Pay): Stockholders approved the compensation of named executive officers on a non-binding advisory basis. The vote was 22,484,128 for, 203,434 against, and 1,646,753 abstained.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Investor Verification Checklist
- Verify the tenure of the newly elected directors, who serve until the 2025 Annual Meeting.
- Confirm the engagement of BPM LLP as the independent auditor for the fiscal year ending December 31, 2024.
- Review the proxy statement for details on the specific compensation packages approved under Proposal 3.
- Note the high volume of broker non-votes on director elections, which may indicate passive institutional ownership.